NASCEND, PBC

Transformative Tech for Brighter Beginnings: Elevating Outcomes for Opioid Exposed Newborns

https://wefunder.com/nascend

Total raised on Wefunder: 161375

Total investors: 26

Quick facts

• CEO & Founder: national expert, physician, Forbes 1000 Entrepreneurs to Watch 2021 & Who's Who 2024
• $6.7M Revenue projected by 2025 with an average ACV of $150K
• $4B total market revenue, currently with no direct competitor
• Today, 7% of pregnant women disclose opioid use in pregnancy
• Over a quarter of a million infants are born opiate exposed each year
• Our outcomes: 84% fewer infants treated resulting in decreased admissions to the neonatal ICU
• Our outcomes: $12.4K cost savings per infant with NAS
• Profit from Purpose: Certified B-Corp, Public Benefit Corporation, and KY Canopy Certified company

Team profiles

• Dawn Forbes, MD
• Weston Burchett
• William J. Ryan

Featured investor profiles

• Keyhorse Capital (KSTC)
• AV RCP LP